Technical Analysis for TLGT - Teligent, Inc.

Grade Last Price % Change Price Change
grade F 1.74 -2.25% -0.04
TLGT closed down 2.25 percent on Friday, January 18, 2019, on 43 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Up
See historical TLGT trend table...

Date Alert Name Type % Chg
Jan 18 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Jan 18 Narrow Range Bar Range Contraction 0.00%
Jan 18 Weak + Overbought Other 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Narrow Range Bar Range Contraction -2.25%
Jan 17 Weak + Overbought Other -2.25%
Jan 17 Wide Bands Range Expansion -2.25%
Jan 17 Overbought Stochastic Strength -2.25%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%

Older signals for TLGT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Teligent, Inc., a specialty generic pharmaceutical company, develops, manufactures, and markets topical formulations in the United States. It sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms under IGI label. The company also develops, manufactures, fills, and packages topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter (OTC) and cosmetic markets. Its products are used in various applications from cosmetics and cosmeceuticals to the prescription treatment of conditions, such as dermatitis, psoriasis, and eczema. In addition, the company offers pharmaceutical contract services comprising formulating, testing, and/or manufacturing prescription drugs and medical devices; and contract development services consisting of developing topical formulations. It has a license agreement with Novavax, Inc. to utilize the Novasome lipid vesicle encapsulation and certain other technologies for applications in animal pharmaceuticals, biologicals, and other animal health products; foods, food applications, nutrients, and flavorings; cosmetics, consumer products, and dermatological OTC and prescription products; fragrances; and chemicals, including herbicides, insecticides, pesticides, paints and coatings, photographic chemicals, and other specialty chemicals. The company was formerly known as IGI Laboratories, Inc. and changed its name to Teligent, Inc. in October 2015. Teligent, Inc. was founded in 1977 and is based in Buena, New Jersey.
Is TLGT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.52
52 Week Low 1.13
Average Volume 409,330
200-Day Moving Average 3.1458
50-Day Moving Average 1.9371
20-Day Moving Average 1.4845
10-Day Moving Average 1.642
Average True Range 0.1617
ADX 31.8
+DI 21.884
-DI 17.9119
Chandelier Exit (Long, 3 ATRs ) 1.3749
Chandelier Exit (Short, 3 ATRs ) 1.6151
Upper Bollinger Band 1.8721
Lower Bollinger Band 1.0969
Percent B (%b) 0.83
BandWidth 52.219603
MACD Line -0.0325
MACD Signal Line -0.1135
MACD Histogram 0.0809
Fundamentals Value
Market Cap 92.9 Million
Num Shares 53.4 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -10.88
Price-to-Sales 4.43
Price-to-Book 5.49
PEG Ratio 5.72
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.86
Resistance 3 (R3) 1.87 1.83 1.84
Resistance 2 (R2) 1.83 1.80 1.83 1.83
Resistance 1 (R1) 1.79 1.78 1.77 1.78 1.83
Pivot Point 1.75 1.75 1.75 1.75 1.75
Support 1 (S1) 1.71 1.72 1.69 1.70 1.65
Support 2 (S2) 1.67 1.70 1.67 1.65
Support 3 (S3) 1.63 1.67 1.64
Support 4 (S4) 1.62